Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Month 2: Office Visit + Enhancing Results Monitor your weekly progress and adjust dosages as needed
.png)
24.2% weight loss at 48 weeks Massive metabolic improvements More research needed on long-term safety Other GLP-1/Glucagon Drugs Survodutide, Pemvidutide, and Cotadutide are in earlier or mid-stage development, with Survodutide showing the strongest results so far
From a research perspective, the comparison question is not just Which is stronger? It is What does the added glucagon-receptor component change? What the Retatrutide Literature Suggests Retatrutides published phase 2 obesity results showed substantial dose-related body-weight reductions at 24 and 48 weeks
Genetic Factors That Influence GLP-1 Energy Response Your genes influence how sensitive your GLP-1 receptors are to medication, which directly affects energy and appetite suppression intensity
